gms | German Medical Science

49. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (gmds)
19. Jahrestagung der Schweizerischen Gesellschaft für Medizinische Informatik (SGMI)
Jahrestagung 2004 des Arbeitskreises Medizinische Informatik (ÖAKMI)

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie
Schweizerische Gesellschaft für Medizinische Informatik (SGMI)

26. bis 30.09.2004, Innsbruck/Tirol

Prospective study on acute lower respiratory tract infection in German children younger than 3 yeas (PRI.DE) : Evaluation of resource utilization and related cost

Meeting Abstract (gmds2004)

  • corresponding author presenting/speaker Birgit Ehlken - MERG, Forschungsgruppe Medizinische Ökonomie, München, Deutschland
  • Karin Berger - MERG, Forschungsgruppe Medizinische Ökonomie, München, Deutschland
  • Gabriele Ihorst - IMBI, Institut für medizinische Statistik, Freiburg, Deutschland
  • Gudula Petersen - Wyeth Pharma GmbH, Münster, Deutschland
  • Johannes Forster - St. Josefskrankenhaus und Universitäts-Kinderkrankenhaus, Freiburg, Deutschland

Kooperative Versorgung - Vernetzte Forschung - Ubiquitäre Information. 49. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (gmds), 19. Jahrestagung der Schweizerischen Gesellschaft für Medizinische Informatik (SGMI) und Jahrestagung 2004 des Arbeitskreises Medizinische Informatik (ÖAKMI) der Österreichischen Computer Gesellschaft (OCG) und der Österreichischen Gesellschaft für Biomedizinische Technik (ÖGBMT). Innsbruck, 26.-30.09.2004. Düsseldorf, Köln: German Medical Science; 2004. Doc04gmds100

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/gmds2004/04gmds100.shtml

Veröffentlicht: 14. September 2004

© 2004 Ehlken et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objectives

To calculate the average cost per patient (case) with lower respiratory tract infection (LRTI) and to show the average cost per case stratified by diagnosis and type of virus in Germany. Costs were evaluated from the perspectives of third party payer, parents and society.

Methods

This economic analysis was part of the PRI.DE study, which was a prospective, multicenter, population-based epidemiological study. It was carried out over 2 years (1999 - 2001) on the impact of community-acquired LRTI in children aged 0 to 36 months in Germany. Inclusion of children with pneumonia, bronchitis, bronchiolitis, croup and apnea by 11 office-based pediatricians in 4 regions in Germany (Bochum, Dresden, Freiburg, Hamburg). Nasopharyngeal secretions were tested for RSV, parainfluenza-(PIV), and influenza viruses (IV) by Hexaplex PCR (Prodesse, USA). Drugs and medical services consumed were generated by chart abstraction. Data regarding parental expenses were collected via telephone interviews within 4 weeks after the first physician visit due to LRTI.

Results

The analysis included data from 1329 cases. A telephone interview was carried out in 654 of these cases. Parents contacted the pediatrician 1.7 times (SD 0.8) per case of LRTI. Approximately 19% of the parents of 654 cases reported additional expenses due to travelling to the physician (private and public transport) and supplemental childcare. About 14% of the parents were absent from work due to LRTI of their children and stayed 0.5 day (mean) at home. In 568 cases total costs could be calculated. Total costs per case were 123 EUR (SD 161 EUR). About 54% were direct medical costs, 11% direct non-medical costs and 35% indirect costs. Cost for pneumonia was 205 EUR (SD 264 EUR); for obstructive bronchitis 146 EUR (SD 179 EUR); for bronchitis 101 EUR (SD 141 EUR) and for croup 82 EUR (SD 78 EUR). Total cost caused by RSV infections amounted to on average 163 EUR (SD 172 EUR), caused by parainfluenza 100 EUR (SD 115 EUR), caused by influenza 223 EUR (SD 279 EUR) and caused by other pathogens 111 EUR (SD 159 EUR).

Discussion

More than half of the total cost was cost from third party payer perspective (German statutory sick funds). Also indirect cost caused a considerable part of the total cost (35%), although only 14% of parents were absent from work due to LRTI of their child. Treatment of bronchiolitis, pneumonia or obstructive bronchitis required more resources than treatment of bronchitis or croup. Average total cost declined with decreasing severity of diagnosis. Treatment of LRTI due to influenza and RSV was more cost-intensive than treatment of LRTI due to parainfluenza or other pathogens.